Neushen Therapeutics Inc. has synthesized 5-HT2A receptor agonists reported to be useful for the treatment of depression, schizophrenia, anxiety and post-traumatic stress disorder.

One of these is the 5-HT2A receptor, which has a recently discovered unique characteristic: It dampens incoming visual ...

New research explores how ayahuasca influences brain circuits involved in fear and anxiety, offering insights into its potential therapeutic uses ...

Explore ayahuasca's effects on anxiety, memory, and emotional processing, revealing its therapeutic potential for ...

The review synthesizes evidence showing that ayahuasca's effects involve a delicate balance between two serotonin receptor types: 5-HT2A and 5-HT1A. This dual action appears crucial for ...

The review synthesizes evidence showing that ayahuasca's effects involve a delicate balance between two serotonin receptor types: 5-HT2A and 5-HT1A. This dual action appears crucial for ...

We propose a multi-site, double-blind, randomized clinical trial of the 5-HT2A receptor agonist psilocybin for smoking cessation. A diverse sample with regard to ethnoracial identity and SES will be ...